JGC
ALIM

J. Goldman & Co’s Alimera Sciences ALIM Stock Holding History

J. Goldman & Co’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-44,557
Closed -$996K – 414
2016
Q3 		$996K Sell
44,557
-95,576
-68% -$2.2M 0.06% 238
2016
Q2 		$2.58M Buy
140,133
+117,786
+527% +$3.13M 0.14% 158
2016
Q1 		$587K Buy
22,347
+17,660
+377% +$550K 0.04% 247
2015
Q4 		$170K Buy
+4,687
New +$203K 0.02% 211

Other funds holding ALIM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

J. Goldman & Co's ALIM Position: Q4 2016 in Review

J. Goldman & Co sold out of Alimera Sciences (ALIM) in Q4 2016, closing a stake of 44,557 shares — an estimated $996K sold.

J. Goldman & Co first reported a position in ALIM in Q4 2015 and held it in 4 quarters. The position peaked at $2.58M in Q2 2016. 47 funds tracked by Wall St. Rank hold ALIM as of Q4 2016.

  • J. Goldman & Co reported no remaining Alimera Sciences position as of Q4 2016 after selling out during the quarter.
  • J. Goldman & Co sold 44,557 Alimera Sciences shares in Q4 2016, an estimated $996K.
  • J. Goldman & Co first reported a position in Alimera Sciences in Q4 2015 and held it in 4 quarters.
  • J. Goldman & Co's Alimera Sciences position peaked at $2.58M in Q2 2016.
  • 47 funds tracked by Wall St. Rank held Alimera Sciences as of Q4 2016.

Based on J. Goldman & Co's 13F filing for Q4 2016, filed 13 Feb 2017.